Although vitamin A supplementation (VAS) can reduce all-cause under-five mortality by 24 percent, its coverage remains low in Nigeria, at 49 percent. Seasonal malaria chemoprevention (SMC), reaching more than 12 million children annually in Nigeria, provides a ready platform for VAS delivery to improve coverage and access. As a follow-up to a previous feasibility study that integrated SMC and VAS delivery, this study aimed to evaluate the effect of full integration of SMC and VAS at scale on vitamin A coverage, SMC coverage, safety, equity and cost.
This poster was presented at the 70th annual meeting of the American Society of Tropical Medicine and Hygiene.
Country: NigeriaKeywords: Community delivery | Use of evidence | Malaria | Seasonal malaria chemoprevention | SDG3
« Back to Publications